In this study, we performed a bioinformatics analysis aimed at assessing the role of GR and TET2 regulation in IBD and elucidating the molecular mechanisms underlying the regulation of downstream genes by GR and TET2 in the disease, along with its potential implications for drug repositioning. This evidence concerns the gene NR3C1 and inflammatory bowel disease.